| Merck (Schweiz) AG - Rebif 22, Injektionslösung in Fertigspritzen |
| 54810 | | 05 | | Rebif 22 | | Injektionslösung in Fertigspritzen | | L03AB07 | | Interferon beta-1a | | 10.10.2008 | | |
|
| Composition |
| interferonum beta-1a ADNr 22 µg corresp. 6 Mio U.I., alcohol benzylicus 2.5 mg, mannitolum, methioninum, poloxamerum 188, natrii acetas trihydricus, natrii hydroxidum, acidum aceticum, aqua ad iniectabile q.s. ad solutionem pro 0.5 ml corresp. natrium max. 0.03 mg. |
| Packungsbestandteile |
| Injection solution in prefilled syringe | | | | | | | | Principe actif | Concentr. |
|---|
| Interferonum Beta-1a Adnr | 22 µg |
| | BAG: Principe actif | Concentr. |
|---|
| Interferonum Beta-1a Adnr | 22 mcg |
| | | | Agents auxilliaires | Concentr. |
|---|
| Acetic Acid | | | Alcohol Benzylicus | 2.5 mg | | Mannitol | | | Methionine | | | Sodium Acetate Trihydrate | | | Sodium Hydroxide | | | Poloxamer | 188 |
| |
|
| numéro d'emballage | Taille des présentations | PEF | PP | Cat. | LS | Hors commerce (MedRef) |
|---|
| 062 | 12 syringe(s) | 717.95 | 797.25 | B | LS | Oui |
|
